Quality of Life

Prof Madeleine King explains the pioneering MOST tool and how it developed in ANZGOG’s Symptom Benefit study

Professor Madeleine King, a former member of ANZGOG’s Research Advisory Committee and a key collaborator on one of ANZGOG’s most important studies – Symptom Benefit - to speak about the development of the MOST instrument in the [...]

Prof Madeleine King explains the pioneering MOST tool and how it developed in ANZGOG’s Symptom Benefit study2024-03-01T11:05:51+11:00

New guidelines for statistical analysis of Quality of Life endpoints in cancer randomised controlled trials

Prof Madeleine King provides advice on the new guidelines for statistical analysis of Quality of Life endpoints in cancer randomised controlled trials. International Standards for the Analysis of Quality of Life and Patient Reported Outcomes Endpoints [...]

New guidelines for statistical analysis of Quality of Life endpoints in cancer randomised controlled trials2020-03-31T06:01:40+11:00
Go to Top